Medicare Enrolled
Dr. Fernando Melaragno, DO
Endocrinology · Erie, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Melaragno from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Melaragno?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Melaragno
Dr. Fernando Melaragno is an endocrinology specialist in Erie, PA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Melaragno performed 382 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Melaragno received a total of $16,730 from 67 pharmaceutical and/or device companies across 991 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Melaragno is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ 382 Medicare services
$16,730 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗382
Medicare services
Bottom 38% in PA for endocrinology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
205 | $67 | $293 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
69 | $9 | $39 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
50 | $26 | $93 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
39 | $94 | $404 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
19 | $51 | $202 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$16,730
Total received (2018-2024)
Avg $2,390/year across 7 years
Top 17% in PA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
991
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,885
2023
$2,477
2022
$2,807
2021
$1,700
2020
$642
2019
$2,572
2018
$3,648
Payments by company (2024)
Novo Nordisk Inc
$458
Lilly USA, LLC
$437
Madrigal Pharmaceuticals
$299
AstraZeneca Pharmaceuticals LP
$257
Amgen Inc.
$193
Abbott Laboratories
$171
Bayer Healthcare Pharmaceuticals Inc.
$143
Medtronic, Inc.
$124
Novartis Pharmaceuticals Corporation
$97
Xeris Pharmaceuticals, Inc.
$90
Boehringer Ingelheim Pharmaceuticals, Inc.
$85
Neurocrine Biosciences, Inc.
$80
CeQur Corporation
$62
Amneal Pharmaceuticals LLC
$53
Antares Pharma, Inc.
$53
PFIZER INC.
$41
SANOFI-AVENTIS U.S. LLC
$38
Alexion Pharmaceuticals, Inc.
$38
Ultragenyx Pharmaceutical Inc.
$26
Kyowa Kirin, Inc.
$26
Corcept Therapeutics
$21
Collegium Pharmaceutical, Inc.
$20
Insulet Corporation
$18
Chiesi USA, Inc.
$17
Teva Pharmaceuticals USA, Inc.
$16
Ascensia Diabetes Care Us Inc.
$15
BETA BIONICS, INC.
$6
Top 3 companies account for 41.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$3,015
AstraZeneca Pharmaceuticals LP
$1,630
Lilly USA, LLC
$1,502
Boehringer Ingelheim Pharmaceuticals, Inc.
$887
SANOFI-AVENTIS U.S. LLC
$783
Amgen Inc.
$753
Medtronic MiniMed, Inc.
$671
Merck Sharp & Dohme Corporation
$595
Abbott Laboratories
$575
Amarin Pharma Inc.
$575
Janssen Pharmaceuticals, Inc
$535
Amneal Pharmaceuticals LLC
$351
Madrigal Pharmaceuticals
$299
Bayer Healthcare Pharmaceuticals Inc.
$293
AbbVie, Inc.
$291
Corcept Therapeutics
$280
Merck Sharp & Dohme LLC
$265
Medtronic, Inc.
$226
Neurocrine Biosciences, Inc.
$211
Xeris Pharmaceuticals, Inc.
$197
Novartis Pharmaceuticals Corporation
$189
CeQur Corporation
$158
Gemini Laboratories, LLC
$153
Insulet Corporation
$151
Antares Pharma, Inc.
$141
Biohaven Pharmaceutical Holding Company Ltd.
$121
Tandem Diabetes Care, Inc.
$120
Horizon Therapeutics plc
$119
Valeritas, Inc.
$99
ABBVIE INC.
$98
ARBOR PHARMACEUTICALS, INC.
$92
Radius Health, Inc.
$91
Biohaven Pharmaceuticals, Inc.
$89
Regeneron Healthcare Solutions, Inc.
$78
PFIZER INC.
$77
Neurelis, Inc.
$76
Teva Pharmaceuticals USA, Inc.
$72
Bayer HealthCare Pharmaceuticals Inc.
$66
LifeScan, Inc.
$60
AbbVie Inc.
$49
Alexion Pharmaceuticals, Inc.
$49
Endo Pharmaceuticals Inc.
$48
Dexcom, Inc.
$47
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$42
E.R. Squibb & Sons, L.L.C.
$39
Boston Scientific Corporation
$37
MannKind Corporation
$33
UCB, Inc.
$32
Alfasigma USA, Inc.
$28
Ultragenyx Pharmaceutical Inc.
$26
Supernus Pharmaceuticals, Inc.
$26
Lundbeck LLC
$26
Kyowa Kirin, Inc.
$26
Ascendis Pharma Inc
$26
RECORDATI_RARE_DISEASES_INC.
$22
EUSA Pharma (US) LLC
$22
GlaxoSmithKline, LLC.
$21
Collegium Pharmaceutical, Inc.
$20
Chiesi USA, Inc.
$17
IBSA Pharma Inc.
$16
Harmony Biosciences LLC
$16
DEXCOM, INC.
$16
Ferring Pharmaceuticals Inc.
$15
SANOFI PASTEUR INC.
$15
Ascensia Diabetes Care Us Inc.
$15
Apria Healthcare LLC
$12
BETA BIONICS, INC.
$6
Top 3 companies account for 36.7% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AIRSUPRA · AJOVY · AREXVY · AUSTEDO · Aimovig · Androgel · Austedo XR · BAQSIMI · BASAGLAR · BELSOMRA · Briviact · CeQur Simplicity · Confirm Rx · Creon · Crysvita · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FLUZONE HIGH-DOSE · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · Gliadel · HUMULIN · INGREZZA · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKAMET · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LANTUS · LEQVIO · LOKELMA · Lupron · Lupron Depot · MOUNJARO · MYCAPSSA · Medela · Minimed 670G System · NASCOBAL · NOCDURNA · NURTEC ODT · Norditropin · Omnipod · OneTouch · Ongentys · Otezla · Otrexup · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · QULIPTA · RECORLEV · RESMETIROM · REXULTI · REZDIFFRA · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · SPECTRA WAVEWRITER · STEGLATRO · STEGLUJAN · STRENSIQ · SUPPRELIN LA · SYNJARDY · SYNTHROID · Saxenda · Strensiq · Sylvant · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Triptodur · Tymlos · UBRELVY · ULTOMIRIS · UNITHROID · V-GO · VALTOCO · Vascepa · Victoza · Wakix · Wegovy · XARELTO · XIFAXAN · XTAMPZA · XYOSTED · ZEPBOUND · ZOMACTON · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
7
County median income
$61,476
Nearest hospital to ZIP centroid (approximate)
LECOM MEDICAL CENTER AND BEHAVIORAL HEALTH PAV
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Melaragno is a clinical cardiology specialist, with moderate Medicare volume, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Melaragno experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Melaragno performed 205 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Melaragno receive payments from pharmaceutical companies?
Yes. Dr. Melaragno received a total of $16,730 from 67 companies across 991 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Melaragno's costs compare to other endocrinologists in Erie?
Dr. Melaragno's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Melaragno) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Erie
Browse endocrinologists in Erie ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in PA
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in PA
Which PA endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology